Phase IIa study successfully met safety and efficacy endpoints including reducing functional and respiratory deterioration and statistically significant changes in ALS-related biomarkers PrimeC has Orphan Drug Designation with the FDA and EMA CAMBRIDGE, Mass., June […]
Pfizer, already flush with cash, will reap $16B from selling shares in GSK consumer health spinoff aliu Wed, 06/01/2022 – 07:40 Click here to view original post Click here to view original post
BOSTON–(BUSINESS WIRE)– #BIO2022–BDO’s BioProcess Technology Group (BPTG), the world leader in providing strategic, technical, regulatory, and business consulting services to the biopharmaceutical industry, will be presenting at the upcoming 2022 BIO International Convention, June 13-16, […]
ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate […]
NORFOLK, Va.–(BUSINESS WIRE)–ReAlta Life Sciences, Inc. (“ReAlta”) a clinical stage, rare disease company addressing life-threatening diseases through harnessing the power of the immune system, today announced the dosing of the first patient in its Phase […]
Level Equity to roll its existing equity and will invest additional capital into the Company NEWPORT BEACH, Calif. and NEW YORK, June 1, 2022 /PRNewswire/ — Planet DDS (the “Company”), a leading provider of cloud-based […]
Ten NAFLD/NASH pipeline product profiles were evaluated by US gastroenterologists and hepatologists to assess strengths, weaknesses, and physician receptivity EXTON, Pa., June 1, 2022 /PRNewswire/ — Spherix recently surveyed 103 US gastroenterologists and 20 hepatologists, […]
IRVINE, Calif.–(BUSINESS WIRE)–Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the American Society of Clinical Oncology (ASCO) 2022 annual meeting data showcasing its new innovative approach to liquid biopsy testing that […]
FOSTER CITY, Calif., June 1, 2022 /PRNewswire/ — OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company will present the latest clinical data and registration plan of TPX-100 in knee osteoarthritis (OA) […]
More than three-quarters of Massachusetts life sciences companies are hiring in the next 12 months, according to a new MassBio report. Click here to view original post
© 2023 Biotech Networks, LLC
